Full-Time

Associate Director

Biostatistics, Statistical Research and Innovation

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures healthcare products and vaccines

Social Impact
Biotechnology
Healthcare

Compensation Overview

$131.2k - $218.6kAnnually

+ Bonus

Senior

New City, NY, USA + 2 more

More locations: Phoenixville, PA, USA | Groton, CT, USA

Hybrid work location assignment with relocation support available.

Category
Computational Biology
Public Health
Biology & Biotech
Required Skills
Data Science
R
Data Analysis
Requirements
  • Ph.D. in Statistics or Biostatics or equivalent postgraduate statistical training.
  • 5 years or more experience in drug development (candidates with less experience will be considered if they have exceptional methodology research credentials and potential).
  • Expert level knowledge in statistical computing (e.g., R and/or SAS).
  • Evidence of creative thinker, professional presence, and scholarship through publications and presentations.
  • Effective verbal and written communication skills in relating to colleagues and associates both inside and outside the organization.
  • Broad-based understanding of statistical theory and its application.
Responsibilities
  • Support effort to increase expertise amongst Pfizer statisticians through dissemination of statistical knowledge, new methodologies, and regulatory guidelines.
  • Be actively involved in the development and implementation of techniques based on state-of-the-art statistical research and seek creative solutions through collaborations and interactions with other experts for drug development problems.
  • Develop effective internal collaborations.
  • Provide external influence through collaborative partnership, scholarship, and professional networking with academic, government and industry statisticians.
  • Provide statistical advice on complex statistical problems arising in Pfizer projects.
  • Support development, implementation, and promotion of methodologies based on state-of-the-art statistical research and dissemination of the results both internally and externally.
  • Perform and assist the implementation of complex and novel study designs and data analyses and the development of specialized software to support them.
  • Support driving innovation by advancing the use of novel statistical/data science methodology and trial designs.
  • Provide consultation on statistical issues to the Statistics Leadership Team, and Pfizer management in Discovery, Clinical Development, Medical Affairs, Regulatory and other pertinent groups.
  • Participate actively in discussions towards key go/no decisions, key regulatory, product defense and publication strategies.
  • Provide a strong presence for Pfizer with regulatory and professional organizations to influence knowledge generation and content of regulatory guidelines and their interpretation in practice.
  • Develop effective collaborations with relevant non-statistical researchers (such as, Clinical, Pharmacology, Development Operations, PharmSci, and Safety).
  • Stay current with research on statistical methodology and its applications pertinent to the Pfizer business needs.
  • Be up to date on training and compliance with all Pfizer SOPs as required based on the assigned curriculum.
  • Mentor new hires and/or junior statisticians.

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its collaboration with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also the distribution of vaccines to underserved communities. The company's goal is to enhance public health by expanding its range of effective treatments and ensuring access to its products worldwide.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnerships accelerate novel cancer therapies development, especially in multiple myeloma.
  • Increased investment in AI enhances Pfizer's innovation pipeline and R&D efficiency.
  • Pfizer's financing in immunotherapies and fibrosis treatments expands its product portfolio.

What critics are saying

  • Slowdown in COVID-19 vaccine demand has led to a slump in Pfizer's shares.
  • Activist investor pressure may lead to strategic changes misaligned with long-term goals.
  • Resource diversion from core operations due to multiple investment ventures.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • The company focuses on innovative medicines and vaccines for global distribution.
  • Pfizer invests in AI-driven drug discovery to enhance R&D efficiency.

Help us improve and share your feedback! Did you find this helpful?